I agree. The fact that so little money was raised

I agree. The fact that so little money was raised should be, in a way, good news. This is not a long-term raise. This is “give me some air to make it to surface”.

Nader makes a good salary and some could (rightfully) say that he does not want a deal quick as every month $1.5M enter to pad his bank count, however, one way or another, if CYDY does not succeed he will be a much poorer man and, I believe, also he will be a failed man.

I still believe in that for NP, bringing Leronlimab to market will be one of his life’s achievements.

And, yes, this is the moment of the truth. A deal with 50% SALES is a good deal depending on who will be selling Lero (how much and how effectively it can sell). We have a good product, solid science and that is what is important.

As I said before, let’s get Combo to the trough the goal post, stop the erosion of the SP, work on Mono (while the SP firms up) and oncology indications (don’t license yet), and up-list at the first opportunity (without reverse split).

I have been a shareholder for long time, and believe me, the deep red does not help with my sleep every night, but, borrowing from Barbara Corcoran: I don’t dare to underestimate the power of my own instinct. Honestly after the FDA letter with the adamantly declaration one does not need instinct anymore, just patience. Lero will be approved.

Eventually we will drink our drinks in beautiful Vegas, Croatia or Thailand or wherever you fancy.

Keep cool.